Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
20961
Effect of indole in combination with cecal SCFAs on <i>hilA</i> expression.
Published 2018“…Data shown are the mean fold decrease (n = 3) in expression of <i>hilA</i> with treatment relative to the control: <i>hilA</i> expression in presence of 200 mM NaCl. * denotes statistical significance relative to cecal SCFAs alone at <i>p</i> < 0.05 using the Student’s <i>t</i>-test. …”
-
20962
-
20963
Table_1_Immunotherapy With Recombinant Alt a 1 Suppresses Allergic Asthma and Influences T Follicular Cells and Regulatory B Cells in Mice.docx
Published 2021“…</p>Methods<p>We synthesized and purified rAlt a 1. Alternaria-sensitized and challenged mice received subcutaneous immunotherapy (SCIT) with four different rAlt a 1 dosages (5, 50, 100, and 150 µg) or PBS only. …”
-
20964
Image_1_Immunotherapy With Recombinant Alt a 1 Suppresses Allergic Asthma and Influences T Follicular Cells and Regulatory B Cells in Mice.tif
Published 2021“…</p>Methods<p>We synthesized and purified rAlt a 1. Alternaria-sensitized and challenged mice received subcutaneous immunotherapy (SCIT) with four different rAlt a 1 dosages (5, 50, 100, and 150 µg) or PBS only. …”
-
20965
Image_2_Immunotherapy With Recombinant Alt a 1 Suppresses Allergic Asthma and Influences T Follicular Cells and Regulatory B Cells in Mice.tif
Published 2021“…</p>Methods<p>We synthesized and purified rAlt a 1. Alternaria-sensitized and challenged mice received subcutaneous immunotherapy (SCIT) with four different rAlt a 1 dosages (5, 50, 100, and 150 µg) or PBS only. …”
-
20966
Evaluation of a Push-Pull Approach for <i>Aedes aegypti</i> (L.) Using a Novel Dispensing System for Spatial Repellents in the Laboratory and in a Semi-Field Environment
Published 2015“…<i>aegypti</i> landing collections decreased significantly by 50% compared to repellent-free controls. …”
-
20967
Inflammation markers, cytokines and pro-inflammatory M1/anti-inflammatory macrophage M2 profile markers in the kidney post IRI.
Published 2021“…These results indicate together with induction of activin A (as shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0252554#pone.0252554.g008" target="_blank">Fig 8</a>), which is involved in M1 polarization state and the decrease in <i>BMP7</i>, which is involved in the M2 polarization state, that the classically activated macrophage M1 is pre-dominant in IRI and independent of NAD+ boosting. …”
-
20968
Blockade by A<sub>2A</sub>R antagonists of the motor output induced by cortical electrical stimulation.
Published 2013“…<p>Dose-dependent decrease in the Power Correlation Coefficient (PCC) induced by the administration of different A<sub>2A</sub>R antagonists. …”
-
20969
-
20970
Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer
Published 2018“…Notably, the disturber peptide TAT-TM6 decreased the binding of bivalent ligand <b>13</b> by 52-fold and had no effect on monovalent compound <b>15</b>, confirming the D<sub>2</sub>R homodimer through TM6 ex vivo. …”
-
20971
Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer
Published 2018“…Notably, the disturber peptide TAT-TM6 decreased the binding of bivalent ligand <b>13</b> by 52-fold and had no effect on monovalent compound <b>15</b>, confirming the D<sub>2</sub>R homodimer through TM6 ex vivo. …”
-
20972
Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer
Published 2018“…Notably, the disturber peptide TAT-TM6 decreased the binding of bivalent ligand <b>13</b> by 52-fold and had no effect on monovalent compound <b>15</b>, confirming the D<sub>2</sub>R homodimer through TM6 ex vivo. …”
-
20973
A Randomized Pilot Trial of a Moderate Carbohydrate Diet Compared to a Very Low Carbohydrate Diet in Overweight or Obese Individuals with Type 2 Diabetes Mellitus or Prediabetes
Published 2014“…Groups met for 13 sessions over 3 months and were taught diet information and psychological skills to promote behavior change and maintenance. At 3 months, mean HbA1c level was unchanged from baseline in the MCCR diet group, while it decreased 0.6% in the LCK group; there was a significant between group difference in HbA1c change favoring the LCK group (−0.6%, 95% CI, −1.1% to −0.03%, <i>p</i> = 0.04). …”
-
20974
-
20975
-
20976
-
20977
-
20978
Time scale separation parameters <i>ϵ</i>, <i>ϵ</i>′ and <i>μ</i>′ control bimodality, time to memory loss, and reactivation time in the chromatin modification circuit.
Published 2022“…In all plots (<i>n</i><sup><i>A</i></sup>, <i>n</i><sup><i>R</i></sup>) ≈ (50, 0) corresponds to the active state and (<i>n</i><sup><i>A</i></sup>, <i>n</i><sup><i>R</i></sup>) ≈ (0, 50) corresponds to the repressed state. …”
-
20979
Expression of <i>BmUbx</i> and <i>Bmabd-A</i> in wildtype and <i>E</i><sup><i>dl</i></sup> mutant in stage 20 embryos.
Published 2017“…(B) Western blot analysis of Bmabd-A. Expression level of Bmabd-A protein was decreased in <i>E</i><sup><i>dl</i></sup> mutants. …”
-
20980